A Human Liver Cell Line Exhibits Efficient Translation of HCV RNAs Produced by a Recombinant Adenovirus Expressing T7 RNA Polymerase  by Aoki, Yoichiro et al.
A Human Liver Cell Line Exhibits Efficient Translation of HCV RNAs Produced
by a Recombinant Adenovirus Expressing T7 RNA Polymerase
Yoichiro Aoki,*,†,1 Hideki Aizaki,* Takashi Shimoike,* Hideki Tani,* Koji Ishii,*
Izumu Saito,† Yoshiharu Matsuura,* and Tatsuo Miyamura*,2
*Department of Virology II, National Institute of Infectious Diseases, Tokyo 162–8640;
and †Institute of Medical Science, University of Tokyo, Tokyo 108–0071, Japan
Received April 7, 1998; returned to author for revision June 19, 1998; accepted August 5, 1998
An in vitro system that supports the efficient growth of hepatitis C virus (HCV) and reflects its complete in vitro replication
cycle has not yet been established. The establishment of a minigene RNA of HCV in mammalian cells could facilitate the
study of virus–cell interactions and the molecular pathogenesis of this virus. We constructed a replication-deficient
recombinant adenovirus expressing bacteriophage T7 RNA polymerase under the control of CAG promoter (AdexCAT7). A
high level of T7 RNA polymerase was detectable for at least 11 days after inoculation. Cells infected with AdexCAT7 were
then transfected with plasmids carrying the authentic T7 promoter, the 59 untranslated region (UTR) of encephalomyocarditis
virus, a luciferase gene, and a T7 terminator (pT7EMCVLuc) or carrying the modified T7 promoter, the 59UTR of HCV, a
luciferase gene, the coding region of C-terminal of NS5B and the 39UTR of HCV, a ribozyme of hepatitis D virus and a T7
terminator (pT7HCVLuc). Most of the cell lines examined supported a higher expression of luciferase by transfection with
pT7EMCVLuc than with pT7HCVLuc. However, one cell line, FLC4, derived from a human hepatocellular carcinoma, exhibited
very high reporter gene expression with pT7HCVLuc. In this cell line, transfection with RNA synthesized in vitro from
pT7HCVLuc induced a higher level of reporter gene expression than RNA from pT7EMCVLuc. The T7-adenovirus system for
the synthesis of HCV minigenes in vivo provides useful information on the molecular mechanisms of HCV translation in
human liver cells. © 1998 Academic Press
INTRODUCTION
Hepatitis C virus (HCV) is a major causative agent of
posttransfusion and sporadic non-A, non-B hepatitis.
HCV has a high propensity to cause chronic hepatitis,
which may progress to liver cirrhosis and to hepatocel-
lular carcinoma (Saito et al., 1990). HCV is distantly re-
lated to pestiviruses and flaviviruses, and its genome
consists of approximately 9400 nucleotides (nt) of posi-
tive-strand RNA encoding a single polyprotein of 3010–
3033 amino acids (Kato et al., 1990; Choo et al., 1991;
Takamizawa et al., 1991).
The genomic structure of HCV, including both the 59
and 39 termini, has been well characterized. The mech-
anisms of processing of the HCV polyprotein have been
investigated by analyses of cDNA expression in vivo and
in vitro under the control of foreign promoters using
different vectors (Trono et al., 1988; Hijikata et al., 1991;
Matsuura et al., 1992; Grakoui et al., 1993). However,
authentic HCV protein may not be identical to these
recombinant cDNA-derived HCV proteins.
Although some lymphocyte cell lines have been shown
to support partial replication of HCV (Shimizu et al., 1992;
Kato et al., 1995), there are currently no efficient in vitro
systems yet to grow HCV. Recently it was reported that a
full-length HCV RNA transcribed from a cDNA clone of
HCV was infectious for a chimpanzee by direct injection
into his liver (Kolyhalov et al., 1997; Yanagi et al., 1997).
However, propagation of the infectious RNA in cell cul-
ture has not been reported so far.
Recombinant vaccinia virus expressing bacteriophage
T7 RNA polymerase (VacT7) has been used for studies
on processing of HCV polyproteins (Grakoui et al., 1993;
Selby et al., 1993). This system was further applied for
recovering infectious viruses from their full-size cDNA
clones of negative-strand RNA viruses like, rabies virus,
vesicular stomatitis virus, respiratory syncytial virus,
Sendai virus, and bunyavirus (Trono et al., 1988; Conzel-
mann and Schnell, 1994; Collins et al., 1995; Garcin et al.,
1995; Lawson et al., 1995; Bridgen and Elliott, 1996; Kato
et al., 1996). However, extensive cytopathic effects (CPE)
caused by replication of a vaccinia virus vector some-
times interfere with a long-term analysis of the ex-
pressed products (Wyatt et al., 1995) and impede infec-
tious virus recovery from their cDNAs.
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The object of this study was to establish a system to
facilitate the analysis of the mechanism of HCV replica-
tion in vivo. To this goal, a replication-deficient recombi-
nant adenovirus expressing T7 RNA polymerase under
the control of the CAG promoter (AdexCAT7) was made.
It circumvents the CPE caused by replication of the
vector virus. To establish a system to examine the trans-
lation efficiency of HCV minigene RNA in vivo, a plasmid
harboring a luciferase gene flanked by 59 and 39 untrans-
lated regions (UTR) of HCV under the T7 promoter was
also made. Following transfection of AdexCAT7-infected
cells with the plasmid, the HCV minigene RNA carrying
the 59 and 39UTR of HCV at both ends of the luciferase
gene was efficiently synthesized in vivo. We examined
various mammalian cells for luciferase expression from
the minigene and found that one human hepatoma cell
line supported efficient expression of HCV minigene
RNA. The HCV minigene system using this cell line is
useful to study the virus-cell interaction of HCV infection
and other viruses for which there are no efficient in vitro
replication systems.
RESULTS
Construction of AdexCAT7
AdexCAT7 was constructed by cotransfecting 293
cells with the pAdexCAT7 and EcoT22l-digested DNA-
terminal protein complex of adenovirus type 5 genome
through homologous recombination (Fig. 1). Purified Ad-
exCAT7 and a control virus AxCAwt were obtained at
titers of 3 3 109 and 4 3 1010 plaque-forming units/ml,
respectively.
Expression of T7 RNA polymerase in various
mammalian cells infected with AdexCAT7
Various mammalian cells were infected with AdexCAT7.
Cell lysates were examined for the polymerase activity by
the incorporation of [3H]UTP using a DNA template con-
taining a T7 promoter and the luciferase gene (pT7Luc,
Fig. 3) (Fig. 2A). A high level of RNA polymerase activity
was demonstrated in all of the cell lines examined. Poly-
merase activity increased with the increase in m.o.i. The
cells infected with AdexCAT7 at an m.o.i. of 100 showed
CPE, therefore m.o.i. 20 was employed throughout the ex-
periments. Mammalian cells infected with AdexCAT7
were harvested periodically and examined for their T7 poly-
merase expression. Western blot analysis revealed con-
tinuous T7 polymerase expression for at least 11 days
postinfection in HepG2 and HeLa cells (Fig. 2B). Cells did
not show any evidence of cytotoxicity during this period.
Similar results were also obtained in other cell lines (data
not shown). No polymerase activity was detected in cells
infected with a control virus containing only the promoter
sequence (AxCAwt).
Transcription of RNA from reporter plasmids
We constructed three reporter plasmids for in vivo RNA
synthesis (Fig. 3). The pT7HCVLuc plasmid possesses a
modified T7 promoter and transcription was expected to
start at the last G residue of the 39 end of the promoter.
Therefore, RNA synthesized from the plasmid should have
an identical sequence with that of the 59UTR of HCV.
pT7Luc has the luciferase gene directly under the control of
the authentic T7 promoter. pT7EMCVLuc carries the 59UTR
sequence of encephalomyocarditis virus (EMCV) preceding
the luciferase gene, which is expressed under the control of
the authentic T7 promoter. In pT7EMCVLuc and pT7Luc,
transcription should start efficiently from the third nucleo-
tide upstream of the 39 end of the authentic T7 promoter
(Fig. 3, bottom line). Therefore, both of the transcripts
should have three extra G residues at the 59 end. Transcrip-
tional efficiency of pT7HCVLuc may thus be lower than that
of pT7EMCVLuc and pT7Luc because of the deletion of the
last two G residues from the promoter sequences (Milligan
et al., 1987).
The transcription efficiencies of these three reporter
plasmids were then compared in various cells infected with
AdexCAT7. Cells were harvested 6 h after transfection, and
transcription levels were measured by Northern blot anal-
ysis (Fig. 4). Efficient transcription was observed in cells
transfected with pT7EMCVLuc and pT7Luc. However, in
HepG2 and Huh7 cells transfected with pT7HCVLuc, no
transcripts were detected. Similar results were obtained in
COS7, HeLa, and CPK cells (data not shown). Only in FLC4
cells were transcripts derived from pT7HCVLuc detected,
although the amounts of the transcript were smaller than
those derived from pT7EMCVLuc and pT7Luc. These re-
sults suggest that the efficiency of transcription from
pT7HCVLuc was enhanced in FLC4 cells.
Determination of terminal sequences of HCV
minigene RNA
The above results indicated that HCV minigene RNA
was transcribed well in FLC4 cells. Further experi-
FIG. 1. Structure of AdexCAT7. The bacteriophage T7 RNA polymer-
ase gene under the control of CAG promoter was inserted into the E1A
and E1B deletion region of the adenovirus genome. The arrow shows
the orientation of the transcription.
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ments were then performed in FLC4 cells. Previous
reports of the successful construction of a full-length
cDNA clone of a flavivirus indicated that authenticity of
the nucleotide sequences at the 59 end of the tran-
scripts was crucial for recovery of the infectious virus
(Rice et al., 1989; Lai et al., 1991; Sumiyoshi et al., 1992;
Boyer and Haenni, 1994; Khromykh and Westaway,
1994). Consequently, it was important to determine the
precise sequence of the 59 terminal region of the HCV
minigene RNA. A 59 RACE method was used to amplify
the 59 end of the transcript, and then the 59UTR se-
quence (position 1–207 nt) was analyzed by PCR-
based direct sequencing. The 39 terminus structure
was determined by the oligo RNA ligation method.
RNA derived from pT7HCVLuc started from the ex-
pected G residue and terminated after poly(T15). This
structure is identical to the HCV minigene sequence in
pT7HCVLuc used for transfection (data not shown).
Expression of luciferase after transfection of
AdexCAT7-infected cells with the reporter plasmids
Cells infected with AdexCAT7 at an m.o.i. of 20 were
transfected with the reporter plasmids and examined
for luciferase activity 24 h after transfection (Fig. 5).
The highest level of luciferase activity was detected in
all the cells transfected with pT7EMCVLuc, whereas
the lowest luciferase activity was recovered in cells
transfected with pT7Luc. The luciferase activity in
cells transfected with pT7HCVLuc except for FLC4
cells was 70- to 140-fold lower than pT7EMCV. How-
ever, luciferase activity in FLC4 cells transfected with
pT7HCVLuc was only three times lower than that of
pT7EMCVLuc-transfected cells despite the lower effi-
ciency of transcription due to the modification of the
T7 promoter (Fig. 4). These results further suggested
that translation efficiency derived from pT7HCVLuc or
FIG. 2. Expression of T7 polymerase in cells infected with AdexCAT7. (A) T7 RNA polymerase activity in cell lysates was measured with a DNA
template containing a T7 promoter. Cells were infected with AdexCAT7 at m.o.i.s of 4, 20, and 100. T7 RNA polymerase activity was assayed as
described under Materials and Methods. Results represent the means of three independent experiments. Standard deviations are represented by
vertical lines. (B) Time course of T7 RNA polymerase expression in HepG2 and HeLa cells infected with AdexCAT7. Cells were infected with AdexCAT7
at an m.o.i. of 20 and harvested at different times. Results represent the means of three independent experiments. Standard deviaitons are
represented by vertical lines. Expression of T7 polymerase was also determined by immunoblotting. The arrows indicate the T7 polymerase proteins.
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stability of the transcript derived from pT7HCVLuc was
significantly increased in FLC4 cells.
Expression of luciferase after transfection with RNA
synthesized in vitro
To examine the possibility that the efficiency of transla-
tion of RNA possessing the 59UTR of HCV is higher than the
EMCV-dependent translation in FLC4 cells, different cell
lines were transfected with RNAs synthesized from the
respective reporter plasmids in vitro and examined for lu-
ciferase activity 4–48 h after transfection (Fig. 6). RNA de-
rived from pT7EMCVLuc showed a similar pattern in all
three cell lines examined; the highest luciferase activity
was observed 4–12 h after transfection and then gradually
decreased. In HeLa and HepG2 cells transfected with RNA
derived from pT7HCVLuc, results similar to those from
pT7EMCVLuc were obtained. In contrast, two- to three-fold
higher luciferase activity was detected in FLC4 cells trans-
fected with RNAs derived from pT7HCVLuc than from
pT7EMCVLuc. In FLC4 cells transfected with HCV mini-
gene RNA, luciferase activity was highest 12 h after trans-
fection and continued until at least 48 h after transfection
(Fig. 6). These results suggested the presence of host cell
factor(s) in FLC4 cells that play some role in increasing the
stability of the HCV minigene RNA and/or the efficiency of
translation of the RNA.
Expression of HCV core protein in FLC4 cells by the
T7-adenovirus system
To determine whether HCV proteins can be synthe-
sized in cells by the T7-adenovirus system, we con-
structed a plasmid, pT7HCVcore, containing the modified
T7 promoter, the HCV 59UTR, the HCV core gene, the
coding region of C-terminal of NS5B and the HCV 39UTR,
rHDV and the T7ter (Fig. 3). FLC4 cells infected with
AdexCAT7 were transfected with pT7HCVcore and exam-
ined for expression of core protein by Western blotting.
The HCV core protein was detected in cell lysates pre-
pared 1–3 days after transfection. No core protein was
expressed in cells infected with the control adenovirus,
AxCAwt (Fig. 7).
DISCUSSION
In this study, we established a system to express the
bacteriophage T7 RNA polymerase by using a replica-
tion-defective recombinant adenovirus. By transfection of
various mammalian cells infected with AdexCAT7 with a
plasmid harboring a minigene of HCV under the modified
T7 promoter, one human hepatoma cell line, FLC4, was
FIG. 3. Structure of reporter plasmids. Reporter plasmids were constructed as described under Materials and Methods. Nucleotide sequences of
authentic and modified T7 promoters and transcription intiation sites of the promoters are indicated at the bottom.
FIG. 4. Transcription of reporter plasmids in vivo. Northern blot
analysis of RNA synthesized in cells infected with AdexCAT7 and
transfected with pT7HCVLuc (lane 1), pT7EMCVLuc (lane 2), or pT7Luc
(lane 3) 24 h after infection. At 6 h after transfection, RNA was extracted
and examined for transcription of the plasmids by Northern blot anal-
ysis as described under Materials and Methods. The arrow indicates
the RNAs synthesized in cells.
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found to increase the stability and the translational effi-
ciency of the RNA.
A vaccinia virus vector expressing T7 RNA polymerase
has been used for transient viral gene expression (Fuerst
et al., 1987). This VacT7 system was particularly effective
when the virus under study did not have an efficient
cell-culture system for replication. The VacT7 system has
contributed significantly to the understanding of the pro-
cessing of HCV polyproteins (Kohara et al., 1992; Spaete
et al., 1992; Grakoui et al., 1993; Selby et al., 1993; Tomei
et al., 1993; Manabe et al., 1994). Furthermore, the VacT7
system has been used in the recovery of infectious RNA
viruses from their cDNA clones (Conzelmann and
Schnell, 1994; Collins et al., 1995; Garcin et al., 1995;
Lawson et al., 1995; Whelan et al., 1995; Kato et al., 1996).
The major benefit of this system is its broad host range,
which permits foreign gene expression in many mamma-
lian cells. However, this system is not suitable for long-
term analysis of the expressed products because of its
extensive CPE, and therefore it cannot be used to re-
cover viruses like HCV whose growth is slow and inef-
ficient. Extensive CPE caused by the vaccinia virus itself
hampers the bona fide virus–cell interaction. In this con-
text, it is noteworthy that an avian host restricted vaccinia
FIG. 5. Expression of reporter plasmids in cells infected with AdexCAT7. Cells were infected with AdexCAT7 or AxCAwt at an m.o.i. of 20 and
transfected with reporter plasmids 24 h after infection. The luciferase activity was measured 24 h after transfection. The firefly luciferase activity is
expressed as relative light units (RLU) per mg of protein after normalization with that of the Renilla luciferase used as an internal standard. Results
represent the means of three independent experiments. Standard deviations are represented by vertical lines. Ad: AxCAwt, AdT7: AdexCAT7.
FIG. 6. Expression of luciferase in cells transfected with RNA. Cells were transfected with RNA transcripts of pT7EMCVLuc or pT7HCVLuc. The cells
were examined for luciferase activity at various time points after transfection. Luciferase activity is expressed as RLU per mg of protein after
normalization with that of the Renilla luciferase used as an internal standard. Results represent the means of three independent experiments.
Standard deviations are represented by vertical lines.
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virus, strain Ankara, has been developed which is less
cytopathic for many cell types (Wyatt et al., 1995).
Recently, Tomanin et al. reported the construction of
replication competent and deficient adenoviruses pos-
sessing the T7 RNA polymerase gene under the control
of the human cytomegalovirus promoter (Tomanin et al.
1997). Although the replication-competent virus exhibited
a high level of T7 polymerase expression in various cell
lines, low-level expression was detected in cell lines
other than 293 after infection with the replication-defi-
cient recombinants. After coinfection with replication-
deficient adenoviruses possessing the T7 polymerase
gene and the reporter gene under the control of the T7
promoter linked to the internal ribosome entry site (IRES)
of EMCV, only low or no reporter activity was detected in
replication-incompetent cell lines. In contrast, the T7-
adenovirus constructed in our study exhibited not only a
high level but long-lasting expression of T7 RNA poly-
merase in various mammalian cells without CPE. This
might be due to the efficiency of the promoter used in the
recombinant viruses. By using a ubiquitously strong pro-
moter, it may be possible to establish a versatile expres-
sion system for various cell lines. We demonstrated here
that this system is applicable to a wide variety of mam-
malian cells. Foreign genes were efficiently expressed
under the control of the T7 promoter in these cells. The
T7 RNA polymerase per se has no capping activity and is
localized in the cytoplasm. Therefore, RNA synthesized
by this system should be uncapped and present in the
cytoplasm. Consequently, an IRES is required for gene
expression in this system. This is in contrast to the VacT7
system in which a portion of the RNA transcript was
modified by the virus-coded capping enzyme (Elroy-Stein
et al., 1989). Conversely, the T7-adenovirus system may
actually provide an advantage for generation of infec-
tious RNA in vivo because of its lack of capping activity.
Infectious cDNA clones have been successfully made for
flaviviruses (Rice et al., 1989; Lai et al., 1991; Gristun and
Gould, 1995; Sumiyoshi et al., 1992). Authenticity of the
sequence at the 59 end of the transcripts was shown to
be crucial for construction of infectious cDNA clones of
these RNA viruses (Boyer and Haenni, 1994). Inappropri-
ate capping at the 59 end by vectors may thus hinder the
authentic structure of the RNA and prevent its infectivity.
Many full-length cDNA clones of HCV have been ob-
tained since the first report of cloning and characteriza-
tion of the prototype HCV cDNA (Choo et al., 1991; Han et
al., 1991; Inchauspe et al., 1991; Kato et al., 1990; Oka-
moto et al., 1991; Tanaka et al., 1996). In most cases, the
starting materials were plasma pools of blood containing
infectious HCV. The cDNA fragments were obtained by
RT–PCR by using many sets of primers derived from the
prototype HCV sequence. Therefore, it is not certain
whether the obtained sequences originated from a sin-
gle genome of an infectious virion of HCV. There is no
sufficient system yet to evaluate the replication of HCV in
vitro or to isolate an infectious particle from the quasi-
species population of HCV. Therefore, it is impossible to
assess the authenticity of the cDNA clones of HCV at
present. Recently, it was demonstrated that a full-length
HCV RNA transcribed from a consensus cDNA clone of
HCV was infectious for a chimpanzee by direct injection
into his liver. However, propagation of infectious RNA in
cell culture has not been reported so far (Kolykhalov et
al., 1997; Yanagi et al., 1997). In the case of an infectious
cDNA clone of classical swine fever virus, only five ami-
no-acid changes abrogated its infectivity (Moormann et
al., 1996).
Instead of full-length clones, establishment of a minigene
of HCV may circumvent this difficulty. A modified T7 pro-
moter in pT7HCVLuc was engineered to generate the au-
thentic HCV 59 end sequence of the transcript by deleting
two Gs. Although deletion of two guanine residues in the
transcription initiation site of the promoter decreases the
efficiency of transcription in comparison with the authentic
one (Milligan et al., 1987), the expression of luciferase in
FLC4 cells was significantly higher than in other cell lines
examined. RNA possessing the 59UTR sequence of EMCV
is efficiently translated via direct entry of the ribosome at a
landing site within the UTR (Bienkowska-Szewczyk and
Ehrenfeld, 1988; Trono et al., 1988; Jan et al., 1989; Pelletier
and Sonenberg, 1989)
Although only a faint signal of transcript from pT7HCVLuc
was detected in FLC4 cells (Fig. 4), the level of luciferase
activity in this cells transfected with pT7HCVLuc was
comparable to in those transfected with pT7EMCVLuc
(Fig. 5). Therefore, we would have expected the transla-
tional efficiency of the RNA possessing HCV 59UTR in
FLC4 cells to be enhanced or stabilized. The level of
expression of luciferase observed in FLC4 cells trans-
fected with the HCV minigene RNA was only two- to
threefold higher than in those transfected with RNA car-
rying the IRES sequence of EMCV (Fig. 6). These results
FIG. 7. Expression of HCV core protein in FLC4 by the T7-adenovirus
system. FLC4 cells were infected with AdexCAT7 (lanes 1–3) or AxCAwt
(lane 4) at an m.o.i. of 20. At 24 h after infection, cells were transfected
with pT7HCVcore and harvested 24 h (lanes 1 and 4), 48 h (lane 2), and
72 h (lane 3) after transfection. As a positive control HCV core proteins
expressed in insect cells by a recombinant baculovirus, Ac39 (Suzuki et
al., 1995), was used (lane 5). The expressed core protein was detected
by Western blot analysis. M is a molecular weight marker.
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suggest the presence of some host factor(s) which in-
crease the efficiency of translation of the HCV minigene
RNA in FLC4 cells. Identification of such host factor(s)
and elucidation of the mechanism of the enhancement of
translation of the HCV minigene RNA in this cell line are
now in progress.
We designed the pT7HCVLuc construct so that the
ribozyme sequence of hepatitis D virus may cleave syn-
thesized RNA immediately after the terminal poly (U)
sequence. However, the presence of an additional 98 nt
of HCV sequence downstream of 39 poly (U) tract was
recently reported (Kolykhalov et al., 1997; Tanaka et al.,
1996). We also detected the additional 98-nt sequence in
both positive and negative strands of HCV RNA (Aizaki et
al., 1998). The effect of the 39 terminal sequence on
transcriptional or translational efficiency in this system
must be determined. So far, however, no difference in
reporter gene expression was observed by the addition
of the 98-nt extra sequence in the 39 end of the
pT7HCVLuc in this system (data not shown). Studies of
replication of the HCV minigene RNA by supplementing
HCV nonstructural proteins with infection with adenovi-
rus vectors are also in progress. The in vivo system used
to synthesize the HCV minigene described in this study
could offer an efficient tool for studies not only of HCV
replication but also of other viruses for which there are
no efficient in vitro replication systems.
MATERIALS AND METHODS
Cells
Cells were maintained in Dulbecco’s modified Eagle’s
medium (GIBCO Laboratories, Grand Island, NY) contain-
ing 2 mM L-glutamine, penicillin (50 IU/ml), streptomycin
(50 mg/ml) and supplemented with 10% fetal calf serum.
Human hepatocellular carcinoma cell lines (HepG2 and
Huh7) were obtained from the American Type Culture
Collection and the Japanese Cancer Research Re-
sources Bank (JCRB)-Cell, Tokyo, respectively. A porcine
kidney cell line (CPK) (Komaniwa et al., 1981) was kindly
provided by Dr. A. Fukusho, National Institute of Animal
Health, Tokyo, Japan. The FLC4 cell lines was estab-
lished by cloning JHH-4 cells (Sujino et al., 1986), and
possesses normal liver functions. The 293 cell line (Gra-
ham et al., 1977) was used for propagation and titration
of recombinant adenoviruses.
Construction of a recombinant adenovirus
The bacteriophage T7 RNA polymerase gene was ex-
cised from pVR-T7–1 (kindly provided by Dr. M. Kohara)
with SmaI and EcoRI, filled with the Klenow enzyme and
cloned into the SwaI site of transfer cosmid pAxCAwt
(Kanegae et al., 1995). The resultant cosmid was desig-
nated pAdexCAT7. The pAxCAwt is a cassette cosmid
containing the CAG promoter and an almost full length
adenovirus type 5 genome with deletions in the E1 (nt
453–3328) and E3 (nt 28592–30474) regions. The CAG
promoter (Niwa et al., 1991), is a composite promoter
consisting to the cytomegalovirus IE enhancer, the
chicken b-actin promoter and the rabbit b-globin poly-
adenylation [poly(A)] signal. Recombinant adenovirus
containing the bacteriophage T7 RNA polymerase, Ad-
exCAT7, was constructed (Fig. 1) as described previously
(Miyake et al., 1996). Briefly, 293 cells were transfected
with pAdexCAT7 together with the DNA-terminal protein
complex of a parent virus by the calcium phosphate
precipitation method (Sambrook et al., 1989). Recombi-
nant virus was plaque-isolated 10 days after transfection.
Viral DNA was extracted together with cellular DNA, and
the desired recombinant was identified by restriction
analysis (Sambrook et al., 1989). The AxCAwt virus
(Kanegae et al., 1995), which did not carry an expression
unit, was used as a control virus. The recombinant vi-
ruses were extensively purified by banding twice through
CsCl density gradients and dialyzed against buffer con-
taining 10 mM Tris–HCl (pH 7.5), 10 mM MgCl2, and 10%
glycerol.
Construction of plasmids
The HCV cDNAs (genotype 1b) used in this study were
originally isolated from a blood sample of an HCV carrier,
which was infectious for both humans and chimpanzees
(NIHJ1 clone) (Aizaki et al., 1998).
To synthesize HCV minigene RNA, pT7HCVLuc (Fig. 3)
was constructed as follows: first, to make pUCT707 con-
taining a modified T7 promoter, the HCV 59UTR and part
of the core region, the clone pUCAB [containing 1–707 nt
(Aizaki et al., 1998)] was modified by the PCR by using 59
primer, 59-AAGCTTAATACGACTCACTAATAGCCAGCCC-
CCGATTGGGGGCGACACTCCAT-39, which contains a
HindIII site and the modified T7 promoter sequence
fused directly to the 59 end of the HCV sequence (under-
lined), and 39 primer, 59-TTGTGATGAGCCGATCGTCA-39.
To generate pUCT7, 59UTRLuc containing the modified
T7 promoter, the 59UTR and the firefly luciferase gene,
pUCT707 was digested with ClaI, filled with Klenow, and
ligated with an 8-mer BamHI linker (59-CGGATCCG-39).
After BamHI and HindII digestion, the fragment was
cloned into the HindIII-BamHI site of the PicaGene vector
(Toyo Ink, Tokyo, Japan) just upstream of the luciferase
gene. To remove the redundant sequences between the
59UTR of HCV and the luciferase gene, the AccI-KasI
fragment of the plasmid was replaced with a DNA frag-
ment synthesized by two oligonucleotides, 59-TAGACC-
GTGCATCATGGAAGACGCCAAAAACATAAAGAAAGGC-
CCGGCGCCATTC-39 (top strand) and 59-GAATGGCGCC-
GGGCCTTTCTTTATGTTTTTGGCGTCTTCCATGATGCAC-
GGTCTA-39 (bottom strand), which contains an AccI site
(327 nt of HCV) at the 59 end and a KasI site (30 nt of the
luciferase gene) at the 39 end. Thus the initiator AUG of
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the luciferase gene in pUCT7 59UTRLuc was located 342
nt downstream from the transcription initiation site which
is identical to the coding sequence of the HCV core
protein. To modify the 39 end of pUCT7 59UTRLuc, the
BspMI-HindIII fragment (nt 9354–9425) of pUCJK (Aizaki
et al., 1998) was replaced with a PCR fragment obtained
by using a set of primers, 59-GCGTCCCAGCTGGACTT-
GTC-39 and 59-TTCGAAATTTTTTTTTTTTTTTCCCCTACC-
GGATAACCGGACC-39, which contained 15 nt of poly (U)
stretch upstream of the DraI site. The cDNA of the mod-
ified pUCJK was digested with Asp718, filled with Klenow
enzyme and ligated with an 8-mer XhoI linker (59-CCTC-
GAGG-39). The two fragments, the HindIII-XhoI fragment
of pUCT7 59UTRLuc and the XhoI-DraI fragment of mod-
ified pUCJK, were cloned between the HindIII-SmaI sites
of pX8dT (kindly provided by Dr. K. Conzelmann), which is
a derivative of pBluescriptII SK(2) (Stratagene, La Jolla,
CA), and the resultant plasmid was designated as
pT7HCVLuc. pT7HCVLuc therefore contained the modi-
fied T7 promoter, the HCV 59UTR (341 nt), the luciferase
gene, a part of NS5B, the HCV 39UTR, a poly (T15) se-
quence, a hepatitis D virus ribozyme sequence (rHDV),
and a T7 promoter termination sequence (T7ter). Tran-
scription of pT7HCVLuc by T7 polymerase was consid-
ered to be initiated from the G residue identical to the
first nucleotide of the 59 end of the HCV and would be
terminated after poly (U15) tailing by self-cleavage activity
of rHDV.
As a positive control, pT7EMCVLuc was constructed
(Fig. 3). This plasmid was constructed by replacing the
T7 promoter and 59UTR of the pT7HCVLuc with the au-
thentic T7 promoter and the 59UTR of EMCV derived from
pTM3 (kindly provided by Dr. B. Moss). As a negative
control, pT7Luc was constructed by deleting the HCV
59UTR derived from pT7HCVLuc and by replacing the
modified T7 promoter with the authentic one (Fig. 3).
To express HCV core protein using the T7-adenovirus
system, pT7HCVcore was constructed (Fig. 3). This plas-
mid contains the modified T7 promoter, the HCV 59UTR,
the HCV core region, a part of NS5B, the HCV 39UTR, the
poly (T15) sequence, rHDV, and T7ter. To normalize the
transfection efficiency, pT7EMCVRLuc was constructed
and used as an internal control plasmid. Renilla lucif-
erase gene was excised from pRL-null (Promega, Mad-
ison, WI) and inserted into the NcoI site of pTM3 under
the authentic T7 promoter and the 59UTR of EMCV.
T7 RNA polymerase assay
Two 3 105 cells in a 12-well plate were infected with
AdexCAT7 at m.o.i.’s of 4, 20, and 100. After 48 h, the cells
were washed three times with phosphate-buffered saline
(PBS), resuspended in 200 ml of PBS and sonicated for 5
min at 30-s intervals. After centrifugation, the cell lysates
were used for in vitro polymerase as follows: a total of 20
ml of a reaction solution containing 1 mg of DNA template
(pT7Luc, Fig 3), 2 ml of lysate, 2 ml of transcription buffer
(MEGAscript kit, Ambion, Austin, TX), and 0.15 mM each
of ATP, CTP, GTP, UTP, and labeled [3H]UTP (37 KBq)
(Daiichi Kagaku, Tokyo) was incubated at 37°C. Fifty
units of enzyme mix containing purified T7 RNA polymer-
ase (Promega) and 2 ml of lysates of uninfected cells was
used as positive and negative controls, respectively. Af-
ter 3 h of incubation, 8 ml of the reaction solution was
spotted onto a filtermat (Wallac, Turku, Finland) and dried
completely in an 80°C oven, then washed three times
with 23 standard saline citrate (0.3 M sodium chloride
and 0.03 M sodium citrate) and twice with 95% ethanol.
After drying, a Meltilex (Wallac) sheet was laid directly on
the dried filtermat and melted at 80°C for 5 min. Subse-
quently the filtermat with meltilex was removed from the
oven, solidified at room temperature and finally placed in
a microbeta counter (1450 Microbeta Plus, Wallac) for
determination of radioactivity.
Expression of luciferase in cells infected with
AdexCAT7
Two 3 105 cells of various cell lines in a 12-well plate
were infected with AdexCAT7 at an m.o.i. of 20. The
inocula were removed after 60 min of incubation and
replaced with 1 ml of fresh medium. After 24 h of incu-
bation, the medium was removed, the cells were washed
twice and the medium was replaced with 500 ml of
Opti-MEM-medium (GIBCO BRL, Life Technologies,
Gaithersburg, MD). Reporter plasmid containing firefly
luciferase gene (1 mg), pT7EMCVRLuc containing Renilla
luciferase gene as an internal control plasmid (0.1 mg)
and lipofectin (GIBCO BRL) (2.5 ml) were mixed with 50 ml
of Opti-MEM and the infected cells were transfected with
the mixture after 15 min of incubation. The cells were
examined for expression of reporter genes at 24 h after
transfection. Firefly and Renilla luciferase activities were
determined by the dual-luciferase reporter assay system
(Promega) following the manufacture’s instructions.
Briefly, cells were washed twice with PBS and lysed with
passive lysis buffer (Promega). After centrifugation, the
cell lysates were used for the assay of two luciferase
reporter enzymes. Since the firefly and Renilla lucif-
erases have dissimilar enzyme structures and substrate
requirements, it is possible to selectively discriminate
between their respective bioluminescent reactions. The
firefly luciferase reporter assay was initiated by adding
the cell lysates to luciferase assay buffer (Promega).
Then to quench of firefly luciferase luminescence and
simultaneously activate the luminescent reaction of Re-
nilla luciferase, Stop and Glo Buffer (Promega) was
added to the same tube. Relative light units (RLU) were
measured with a luminometer (Berthold, Wildbad, Ger-
many), and firefly luciferase activity was normalized with
that of Renilla luciferase. Total protein was quantified by
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using BCA protein assay reagents (Pierce Chemical Co.,
Rockford, IL).
Northern blot analysis
Total RNA was prepared from cells infected with Ad-
exCAT7 and then transfected with the reporter plasmids
by RNA zol B (Cinna/Biotecx, Friendswood, TX). RNA was
denatured at 65°C for 15 min in 5.8 ml of sample buffer
(17.5% formaldehyde and 50% formamide in 13 MOPS
buffer, 20 mM MOPS, 5 mM sodium acetate, and 1 mM
EDTA pH 7.0). After cooling in ice-cold water, the RNA in
7.5 ml of 23 loading buffer (80% formamide, 0.1% brom-
phenol blue, 0.1% xylene cyanol, 2 mM EDTA) was sep-
arated on a formaldehyde-denatured agarose gel (18%
formaldehyde, 1% agarose) in 13 MOPS buffer. The gel
was washed twice with 203 SSC (3 M NaCl, 0.3 M
trisodium citrate dihydrate, pH 7.0) for 15 min and trans-
ferred onto a Hybond N1 membrane filter (Amersham
Life Science, Buckinghamshire, England) by the capillary
method. The filter was dried and RNAs were fixed on the
membrane with UV light (UV Crosslinker, Funakoshi, To-
kyo). The RNA was randomly labeled with digoxigenin
(DIG)-UTP in vitro using the luciferase gene as a tem-
plate. Luciferase-specific RNA was detected with a DIG
luminescent detection kit (Boehringer GmbH, Mannheim,
Germany) according to the manufacturer’s protocol.
The nucleotide sequences of the 59 and 39 UTRs of
the HCV minigene RNA using AdexCAT7
Total RNA was extracted from cells infected with Ad-
exCAT7 and then transfected with pT7HCVLuc as de-
scribed above. The nucleotide sequence of the 59 termi-
nus position was determined after amplification of the 59
terminus region using the 59 RACE for rapid amplification
of cDNA ends kit (GIBCO BRL). Briefly, first strand cDNA
was synthesized from total RNA using a 20-mer primer,
Aa1 (59)-GTTGATCCAAGAAAGGACCC-39) (Aizaki et al.,
1998) using reverse transcriptase (Takara Shuzo, Kyoto).
A homopolymeric tail, using dCTP and terminal deoxyl
terminal transferase, was then added to the 39 end of
cDNA. The 59 terminus sequence (position 1 to 207) was
determined by PCR-based sequencing using the M13RV
(59-CAGGAAACAGCTATGAC-39) and J36A primers.
The nucleotide sequence of the 39 terminus position was
determined by the oligo RNA ligation method (Tanaka et
al., 1996). Briefly, the 59-phosphorylated oligo RNA (59-CCC-
GUCUUCGGACAUCCAGAGGUAU-39) was synthesized
(Takara Shuzo) and ligated to RNA by T4 RNA ligase
(Takara Shuzo) at 10°C for 15 h and then reverse tran-
scribed with primer La1 (59-CCATCCTAATACGACTCAC-
TATAGGGC-39) at 50°C for 1 h. The reverse transcript
was amplified by nested PCR (94°C for 1 min, 55°C for 1
min, 72°C for 2 min, 40 cycles) with sets of the primers
(1st PCR: Ks1; 59-TACTCCTACTCTCTGTAGGG-39 and
La1; 2nd PCR: Ks2; 59-GGCATCTACCTGCTCCCCAA-39
and La2; 59-ACTCACTATAGGGCTCGAGCGGC-39). The 39
terminus sequences were determined by PCR-based se-
quencing
In vitro transcription
RNAs were synthesized with a MEGAscript kit accord-
ing to the manufacturer’s instruction. Briefly, the tran-
scription reaction was carried out at 37°C for 2 h in a
total 20 ml reaction solution containing 1 mg of DNA
template, 2 ml of 103 transcription buffer, 2 ml of enzyme
mix, 2 ml of 103 transcription buffer, 2 ml each of 75 mM
ATP, CTP, GTP, and UTP. The mixture was treated twice
with 8 units of DNase at 37°C for 20 min and precipitated
with ethanol. After being washed with 75% ethanol, the
precipitate was dissolved in water.
RNA transfection
Cells (2 3 105) in a 12-well plate were washed twice
with 500 ml of Opti-MEM (GIBCO BRL) medium and
replaced with the same volume of Opti-MEM medium. In
vitro-synthesized RNA (2 mg) and lipofectin (GIBCO BRL)
(2.5 ml) were mixed with 50 ml of Opti-MEM, and cells
were transfected with the mixture after 15 min of incu-
bation. To normalize the transfection efficiency, RNA syn-
thesized from pT7EMCVRLuc was used as an internal
control. At 6 h after transfection, the cells were harvested
for luciferase assay as described above.
Western blot
Cell extracts were separated by sodium dodecyl sul-
fate polyacrylamide gel electrophoresis, and proteins
were blotted onto a polyvinylidene difluoride membrane
(Millipore, Tokyo). Anti-T7 polymerase rabbit polyclonal
antibody (kindly provided by Dr. F. W. Studdier) and a
mouse monoclonal antibody raised against the core pro-
tein of HCV (Suzuki et al., 1995) were used as the first
antibody. The expressed proteins were detected with an
alkaline phosphatase assay kit (Bio-Rad Laboratories,
Hercules, CA).
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